Dr. Sulaiman Al Habib Medical Services Group Company
Saudi ExchangeTotal Valuation
Dr. Sulaiman Al Habib Medical Services Group Company carries a market capitalization of 76.20B, placing it among publicly traded companies globally. Its enterprise value stands at 102.24B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 76.20B |
| Enterprise Value | 102.24B |
Share Statistics
Dr. Sulaiman Al Habib Medical Services Group Company currently has 350.00M shares outstanding.
| Shares Outstanding | 350.00M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Dr. Sulaiman Al Habib Medical Services Group Company trades at a trailing price-to-earnings ratio of 40.27. The price-to-sales ratio is 7.51, and the price-to-book ratio stands at 12.66.
| PE Ratio | 40.27 |
| PS Ratio | 7.51 |
| PB Ratio | 12.66 |
| P/TBV Ratio | 11.91 |
| P/FCF Ratio | 13.98 |
| P/OCF Ratio | 29.12 |
Enterprise Valuation
On an enterprise value basis, Dr. Sulaiman Al Habib Medical Services Group Company trades at an EV/EBITDA multiple of 40.31 and an EV/FCF ratio of 14.46. The EV/Sales ratio of 8.08 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 40.31 provides insight into valuation relative to core operating earnings.
| EV / Sales | 8.08 |
| EV / EBITDA | 40.31 |
| EV / EBIT | 40.31 |
| EV / FCF | 14.46 |
Financial Position
Dr. Sulaiman Al Habib Medical Services Group Company maintains a current ratio of 1.18, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 113.40, indicating elevated leverage, while an interest coverage ratio of 8.87 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.18 |
| Quick Ratio | 0.45 |
| Debt / Equity | 113.40 |
| Debt / EBITDA | 3.56 |
| Interest Coverage | 8.87 |
Financial Efficiency
Dr. Sulaiman Al Habib Medical Services Group Company posts a return on equity of 32.98 and a return on invested capital of 16.49.
| Return on Equity (ROE) | 32.98 |
| Return on Assets (ROA) | 11.84 |
| Return on Invested Capital (ROIC) | 16.49 |
| Return on Capital Employed (ROCE) | 17.15 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 9.08 |
Taxes
Over the trailing twelve months, Dr. Sulaiman Al Habib Medical Services Group Company has paid 38.46M in income taxes, reflecting an effective tax rate of 1.57.
| Income Tax | 38.46M |
| Effective Tax Rate | 1.57 |
Stock Price Statistics
Dr. Sulaiman Al Habib Medical Services Group Company's stock has declined approximately -19.07063% over the past 52 weeks. The 50-day moving average sits at 219.86, while the 200-day moving average is 247.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | -19.07063% |
| 50-Day Moving Average | 219.86 |
| 200-Day Moving Average | 247.00 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Dr. Sulaiman Al Habib Medical Services Group Company generated 12.65B in revenue and converted that into 2.36B in net income, yielding earnings per share of 6.91. EBITDA reached 2.54B, while operating income came in at 2.54B.
| Revenue | 12.65B |
| Gross Profit | 4.08B |
| Operating Income | 2.54B |
| Pretax Income | 2.46B |
| Net Income | 2.36B |
| EBITDA | 2.54B |
| EBIT | 2.54B |
| Earnings Per Share (EPS) | 6.91 |
Balance Sheet
Dr. Sulaiman Al Habib Medical Services Group Company holds 2.18B in cash and equivalents against 9.03B in total debt, resulting in a net debt position of 6.40B. Total book value stands at 7.49B, with working capital of 859.40M providing operational flexibility.
| Cash & Cash Equivalents | 2.18B |
| Total Debt | 9.03B |
| Net Debt | 6.40B |
| Equity (Book Value) | 7.49B |
| Book Value Per Share | 21.41 |
| Working Capital | 859.40M |
Cash Flow
Dr. Sulaiman Al Habib Medical Services Group Company produced 3.26B in operating cash flow over the past twelve months. After subtracting -3.53B in capital expenditures, free cash flow totaled -270.53M - equivalent to -0.77 per share.
| Operating Cash Flow | 3.26B |
| Capital Expenditures | -3.53B |
| Free Cash Flow | -270.53M |
| FCF Per Share | -0.77 |
Margins
Dr. Sulaiman Al Habib Medical Services Group Company operates with a gross margin of 32.28, reflecting its pricing power and cost economics. The operating margin of 20.05 and net profit margin of 18.64 provide insight into operational efficiency.
| Gross Margin | 32.28 |
| Operating Margin | 20.05 |
| Pretax Margin | 19.43 |
| Profit Margin | 18.64 |
| EBITDA Margin | 20.05 |
Dividends & Yields
The company's payout ratio of 66.60 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 4.72 |
| Dividend Yield | N/A |
| Payout Ratio | 66.60 |
| Shareholder Yield | -1.13 |
| FCF Yield | 7.15 |
Scores
Dr. Sulaiman Al Habib Medical Services Group Company posts an Altman Z-Score of 5.15, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 5.15 |